Hyundai Bioscience
No substantive content was available at the provided URL. The server returned an HTTP 406 Not Acceptable response (nginx), so mission, vision, and company details could not be extracted.
Industries
biotechnology
electrical-distribution
Nr. of Employees
medium (51-250)
Hyundai Bioscience
Seoul, Seoul-t'ukpyolsi, South Korea, Asia
Patents
Metal hydroxide complex comprising modified multilayer hydroxide structure comprising active ingredient and method of manufacturing same
US-12297213-B2
View DetailsCarrier composition for eye drops and pharmaceutical composition including the same
US-11260104-B2
View Details
Metal hydroxide complex comprising modified multilayer hydroxide structure comprising active ingredient and method of manufacturing same
US-12297213-B2
View DetailsCarrier composition for eye drops and pharmaceutical composition including the same
US-11260104-B2
View DetailsProducts
CP-COV03
A broad-spectrum antiviral drug that enhances autophagy to help infected cells eliminate viruses, treating a wide range of viral infections including COVID-19.
Polytaxel
An anticancer drug using polymer delivery technology to reduce toxicity and pain associated with chemotherapy.
Organic-Inorganic Hybrid Technologies
A drug delivery technology that uses bio-friendly inorganic substances as carriers to selectively and effectively deliver bioactive compounds or therapeutic drugs.
CP-COV03
A broad-spectrum antiviral drug that enhances autophagy to help infected cells eliminate viruses, treating a wide range of viral infections including COVID-19.
Polytaxel
An anticancer drug using polymer delivery technology to reduce toxicity and pain associated with chemotherapy.
Organic-Inorganic Hybrid Technologies
A drug delivery technology that uses bio-friendly inorganic substances as carriers to selectively and effectively deliver bioactive compounds or therapeutic drugs.